Cytonics, founded in 2006, is a private research and development company focused on developing molecular diagnostics and therapeutics for chronic musculoskeletal diseases such as osteoarthritis. The companyâs flagship product was a diagnostic test which helps identify the source of joint pain and assists physicians in determining the most appropriate course of treatment.
No articles found.
Personalis, Inc. is a growing cancer genomics company transforming the development...
Personalis, Inc. is a growing cancer genomics c...
T2 Biosystems, a leader in the development and commercialization of innovative med...
T2 Biosystems, a leader in the development and ...
AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage co...
AVROBIO, Inc., a leader in lentiviral-based gen...
It is the mission of YogaBody Studios, Inc to create a space for yoga and wellness...
It is the mission of YogaBody Studios, Inc to c...
lululemon athletica inc. (NASDAQ:LULU) is a healthy lifestyle inspired athletic ap...
lululemon athletica inc. (NASDAQ:LULU) is a hea...
ShapeScale is a weight scale that digitizes your body in 3D, so you can see exactl...
ShapeScale is a weight scale that digitizes you...
Eclipes Diagnostics develops CANABINOX, a handheld testing device that can accurat...
Eclipes Diagnostics develops CANABINOX, a handh...
Join the National Investor Network and get the latest information with your interests in mind.